Abstract:
Background In late December 2019, a series of cases of Coronavirus Disease 2019 were discovered in Wuhan, Hubei. The disease rapidly spread to other provinces in China and continued to spread around the world. Most patients manifested as mild or moderate type. Some patients, especially those with underlying diseases or the elderly, are prone to have severe complications and significantly higher mortality rates.
Objective To analyze the association between the major complications of patients with Coronavirus Disease 2019 (COVID-19) and underlying diseases, and provide evidences for clinical prediction of severe complications and early medical intervention.
Methods In this retrospective study, 2 079 confirmed COVID-19 cases in Huoshenshan Hospital were included from February 4, 2020 to March 30, 2020. Three kinds of most significant complications related to death were recorded. Logistic regression analysis was performed analyze the impact of their underlying diseases.
Results Of the 2 079 patients, 1 085 were male (52.19%) and 994 were female (47.81%). The patients aged 14 to 100 (58.460±14.477) years, 1 088 cases (52.33%) had at least one underlying disease, and 173 cases (8.32%) developed at least one complication. Death occurred in 49 patients (2.36%). There was significant difference in age between the survival group and the death group (P<0.001), but no significant difference was found in sex. Multiple organ failure (χ2=696.596, P<0.001), respiratory failure (χ2=391.827, P<0.001), and shock (χ2=389.881, P<0.001) were the three major complications significantly associated with death. Hypoproteinemia (OR=4.010, P=0.038), heart disease (OR=4.088, P=0.002) and diabetes (OR=2.953, P=0.017) were associated with multiple organ failure. Hypoproteinemia (OR=5.936, P<0.001), heart disease (OR=3.541, P=0.001) and diabetes (OR=2.447, P=0.013) were also significantly associated with respiratory failure. Hypoproteinemia (OR=19.797, P<0.001) was significantly associated with shock.
Conclusion Underlying diseases can increase the risk of complications, especially for patients with hypoproteinemia, heart disease and diabetes. Early attention and timely intervention can potentially improve their clinical outcomes.